High Dose Ara‐C Combined with Autologous Peripheral Blood Stem Cell Transplantation in the Treatment of Acute Myelogenous Leukemia: The Question is Still Not Answered
- 1 November 2000
- journal article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 18 (6) , 459-460
- https://doi.org/10.1634/stemcells.18-6-459
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- N ew S trategies in the T reatment of A cute M yelogenous L eukemia : M obilization and T ransplantation of A utologous P eripheral B lood S tem C ells in A dult P atientsThe International Journal of Cell Cloning, 2001
- High Dose Ara‐C Combined with Autologous Peripheral Blood Stem Cell Transplantation in the Treatment of Acute Myelogenous Leukemia: The Question is Still Not AnsweredThe International Journal of Cell Cloning, 2000
- No impact of high‐dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remissionBritish Journal of Haematology, 2000
- Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparisonLeukemia, 1998
- A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]Blood, 1996
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994